Pharmacological treatment for muscle weakness and wasting in myotonic dystrophy
Editorial Group: Cochrane Neuromuscular Disease Group
Published Online: 17 FEB 2010
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Turner C, Hilton-Jones D. Pharmacological treatment for muscle weakness and wasting in myotonic dystrophy (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 2. Art. No.: CD008377. DOI: 10.1002/14651858.CD008377.
- Publication Status: New
- Published Online: 17 FEB 2010
This is the protocol for a review and there is no abstract. The objectives are as follows:
To prepare a systematic review of randomised controlled trials (RCTs) of pharmacological treatment for DM1 and DM2. If RCTs do not exist, the need for RCTs and the most appropriate trial designs and outcomes will be considered in the discussion in the context of non-randomised studies.